02
Mar
2011
Posted in I - Series D, Q - 1Q11, R - SOUTH WEST, X - Device (Diagnostic), X - mRNA, X - miRNA, XX - AZ
HTG (Tuscon, AZ) a commercial-stage molecular technology company focused on gene expression profiling, miRNA and mRNA measurement, translational medicine and diagnostic applications, closed a $15.7M Series D financing. Participants include Novo Ventures, Fletcher Spaght Ventures, Merck Capital Ventures, Solstice Capital and Valley Ventures.
13
May
2010